The decrease in PMN-MDSC recruitment and inhibition of immunosuppressive functions caused by the Sema4D mAb enhances the specific responses of T cells to tumor antigens, thus potentially explaining the increased immune response to PD1 blockade86. This evidence concerns the gene SEMA4D and neoplasm.